For example, mutations of the BRD-containing protein SMARCA4 in tumor cells results in a unique functional dependence on SMARCA2. Thus, SMARCA2 serves as a potential therapeutic target for SMARC4-mutant cancers41. This evidence concerns the gene SMARCA4 and neoplasm.